Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 2
1951 4
1952 1
1953 3
1954 2
1955 3
1956 4
1957 1
1959 1
1960 1
1961 15
1962 23
1963 28
1964 38
1965 25
1966 48
1967 32
1968 43
1969 43
1970 48
1971 61
1972 47
1973 48
1974 70
1975 51
1976 69
1977 90
1978 72
1979 85
1980 81
1981 112
1982 117
1983 138
1984 160
1985 177
1986 200
1987 244
1988 248
1989 252
1990 230
1991 261
1992 272
1993 281
1994 268
1995 275
1996 279
1997 245
1998 302
1999 287
2000 322
2001 339
2002 278
2003 316
2004 324
2005 368
2006 430
2007 380
2008 379
2009 378
2010 438
2011 447
2012 521
2013 515
2014 546
2015 569
2016 588
2017 635
2018 685
2019 647
2020 762
2021 893
2022 852
2023 731
2024 464
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

16,755 results

Results by year

Filters applied: . Clear all
Page 1
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation.
Chen CW, Zhang L, Dutta R, Niroula A, Miller PG, Gibson CJ, Bick AG, Reyes JM, Lee YT, Tovy A, Gu T, Waldvogel S, Chen YH, Venters BJ, Estève PO, Pradhan S, Keogh MC, Natarajan P, Takahashi K, Sperling AS, Goodell MA. Chen CW, et al. Among authors: takahashi k. Cell Stem Cell. 2023 Nov 2;30(11):1503-1519.e8. doi: 10.1016/j.stem.2023.09.011. Epub 2023 Oct 19. Cell Stem Cell. 2023. PMID: 37863054
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, Tsuzuki A, Takahashi K, Miya A, Kameda H, Cho KY, Takeuchi J, Nagai S, Taneda S, Kurihara Y, Nakamura A, Atsumi T; SWITCH-SEMA 2 study group. Furusawa S, et al. Among authors: takahashi k. Diabetes Obes Metab. 2024 Mar;26(3):961-970. doi: 10.1111/dom.15393. Epub 2023 Dec 11. Diabetes Obes Metab. 2024. PMID: 38073422 Clinical Trial.
Man with bedsores.
Shirahige H, Aoki Y, Takahashi K, Akao K, Hirabaru M, Akashi R, Yoshino K, Tachikawa A, Sugawara D, Tsukamoto Y, Atsumi T, Yamano S, Morino S, Nakano M, Hayakawa K, Tasaki O. Shirahige H, et al. Among authors: takahashi k. J Am Coll Emerg Physicians Open. 2024 Jun 16;5(3):e13215. doi: 10.1002/emp2.13215. eCollection 2024 Jun. J Am Coll Emerg Physicians Open. 2024. PMID: 38887224 Free PMC article. No abstract available.
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax.
Bataller A, Bazinet A, DiNardo CD, Maiti A, Borthakur G, Daver NG, Short NJ, Jabbour EJ, Issa GC, Pemmaraju N, Yilmaz M, Montalban-Bravo G, Takahashi K, Loghavi S, Garcia-Manero G, Ravandi F, Kantarjian HM, Kadia TM. Bataller A, et al. Among authors: takahashi k. Blood Adv. 2024 Feb 27;8(4):927-935. doi: 10.1182/bloodadvances.2023011757. Blood Adv. 2024. PMID: 38113472 Free PMC article.
Development of lung tissue models and their applications.
Petpiroon N, Netkueakul W, Sukrak K, Wang C, Liang Y, Wang M, Liu Y, Li Q, Kamran R, Naruse K, Aueviriyavit S, Takahashi K. Petpiroon N, et al. Among authors: takahashi k. Life Sci. 2023 Dec 1;334:122208. doi: 10.1016/j.lfs.2023.122208. Epub 2023 Oct 24. Life Sci. 2023. PMID: 37884207 Review.
Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
Hashimoto M, Kojima Y, Sakamoto T, Ozato Y, Nakano Y, Abe T, Hosoda K, Saito H, Higuchi S, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Hata T, Nagayama S, Kagawa K, Goto Y, Utou M, Gamachi A, Imamura K, Kuze Y, Zenkoh J, Suzuki A, Takahashi K, Niida A, Hirose H, Hayashi S, Koseki J, Fukuchi S, Murakami K, Yoshizumi T, Kadomatsu K, Tobo T, Oda Y, Uemura M, Eguchi H, Doki Y, Mori M, Oshima M, Shibata T, Suzuki Y, Shimamura T, Mimori K. Hashimoto M, et al. Among authors: takahashi k. EBioMedicine. 2024 May;103:105102. doi: 10.1016/j.ebiom.2024.105102. Epub 2024 Apr 12. EBioMedicine. 2024. PMID: 38614865 Free PMC article.
Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts.
Takeuchi K, Tabe S, Takahashi K, Aoshima K, Matsuo M, Ueno Y, Furukawa Y, Yamaguchi K, Ohtsuka M, Morinaga S, Miyagi Y, Yamaguchi T, Tanimizu N, Taniguchi H. Takeuchi K, et al. Among authors: takahashi k. Cell Rep. 2023 Nov 28;42(11):113420. doi: 10.1016/j.celrep.2023.113420. Epub 2023 Nov 12. Cell Rep. 2023. PMID: 37955987 Free article.
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Thongon N, Ma F, Baran N, Lockyer P, Liu J, Jackson C, Rose A, Furudate K, Wildeman B, Marchesini M, Marchica V, Storti P, Todaro G, Ganan-Gomez I, Adema V, Rodriguez-Sevilla JJ, Qing Y, Ha MJ, Fonseca R, Stein C, Class C, Tan L, Attanasio S, Garcia-Manero G, Giuliani N, Berrios Nolasco D, Santoni A, Cerchione C, Bueso-Ramos C, Konopleva M, Lorenzi P, Takahashi K, Manasanch E, Sammarelli G, Kanagal-Shamanna R, Viale A, Chesi M, Colla S. Thongon N, et al. Among authors: takahashi k. Nat Commun. 2024 Feb 8;15(1):1203. doi: 10.1038/s41467-024-45350-8. Nat Commun. 2024. PMID: 38331987 Free PMC article.
16,755 results
You have reached the last available page of results. Please see the User Guide for more information.